Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
There is a donated kidney shortage in the U.S. It’s leaving more than 100,000 people on a years-long waitlist. And despite ...
An approval for the first drug for a rare lipid storage disease, some FDA workers rehired, and other biotech news of the day ...
Type C Meeting Requested to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, Feb. 24, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc.
Political and business leaders are rethinking AI—as not just a technology to regulate but as a force to accelerate. Medicine ...
Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...
As the number of people diagnosed with diabetes continues to grow, an increasing number of products marketed under the guise of "dietary supplements" or "over-the-counter drugs" promising to prevent, ...
Millions of Americans take proton pump inhibitors (PPIs) like Prilosec, Nexium, and Prevacid to manage acid reflux, heartburn, and gastroesophageal reflux disease (GERD).
AstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...
An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
The results showed that people who took sotagliflozin had a 23% lower risk of heart attacks, strokes, and death from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results